GUFICBIO.NSGUFICBIO.NSNSE

Revenue (LTM)

$8.2B

+1.6% YoY

Net Income (LTM)

$696M

-19.1% YoY

Free Cash Flow

$271M

Revenue CAGR (5Y)

+16.7%

—Marginsstable

FCFTurned positive

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	4,877	7,792↑59.8%	6,906↓11.4%	8,067↑16.8%	8,198↑1.6%
Gross Profit	2,312	3,563↑54.1%	3,513↓1.4%	4,074↑16.0%	2,970↓27.1%
Operating Income	681	1,291↑89.4%	2,521↑95.3%	2,894↑14.8%	1,136↓60.7%
Net Income	442	958↑116.7%	797↓16.8%	861↑8.1%	696↓19.1%
EBITDA	858	1,485↑73.1%	1,372↓7.6%	1,480↑7.9%	1,383↓6.6%
EPS Diluted	4.56	9.89↑116.9%	8.22↓16.9%	8.74↑6.3%	6.96↓20.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	62	116↑87.2%	286↑146.4%	11↓96.0%	290↑2453.0%
Total Current Assets	2,606	3,208↑23.1%	4,641↑44.7%	6,005↑29.4%	6,245↑4.0%
Total Assets	3,921	5,214↑33.0%	8,612↑65.2%	10,925↑26.9%	11,694↑7.0%
Total Current Liabilities	1,637	1,864↑13.9%	2,882↑54.6%	3,720↑29.1%	3,876↑4.2%
Total Liabilities	2,186	2,523↑15.4%	5,134↑103.5%	5,600↑9.1%	5,683↑1.5%
Total Equity	1,734	2,691↑55.2%	3,478↑29.2%	5,326↑53.1%	6,011↑12.9%
Total Debt	615	644↑4.6%	3,342↑419.0%	3,329↓0.4%	3,362↑1.0%
Net Debt	553	528↓4.6%	3,056↑479.0%	3,318↑8.6%	3,072↓7.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	873	1,062↑21.8%	-266↓125.0%	-75↑72.0%	1,026↑1476.2%
Capital Expenditure	-124	-875↓605.3%	-1,876↓114.5%	-1,127↑39.9%	-755↑33.0%
Free Cash Flow	749	188↓74.9%	-2,142↓1240.1%	-1,202↑43.9%	271↑122.6%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	19	54↑178.7%	170↑214.3%	-275↓261.6%	279↑201.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance